Chemical Structure : Raltegravir potassium salt
CAS No.: 871038-72-1
Catalog No.: PC-42549Not For Human Use, Lab Use Only.
Raltegravir potassium salt (MK-0518) is a potent, selective, orally bioavailable HIV-integrase inhibitor with IC50 of 15 nM.
Packing | Price | Stock | Quantity |
---|---|---|---|
10 mg | $78 | In stock | |
25 mg | $118 | In stock | |
50 mg | $188 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Raltegravir potassium salt (MK-0518) is a potent, selective, orally bioavailable HIV-integrase inhibitor with IC50 of 15 nM.
Raltegravir essentially inactive (IC50s>50 uM) against HCV Pol, HIV RT, HIV RNase-H, and human α/β/γ Pol.
Raltegravir shows inhibitory activity against the wild type virus and a selection of mutants.
Raltegravir is the first HIV-integrase inhibitor for the treatment of HIV-1 infection.
M.Wt | 482.5067 | |
Formula | C20H20FKN6O5 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-, potassium salt(1:1) |
1. Summa V, et al. J Med Chem. 2008 Sep 25;51(18):5843-55.
2. Malet I, et al. Antimicrob Agents Chemother. 2008 Apr;52(4):1351-8.
3. Cooper DA, et al. N Engl J Med. 2008 Jul 24;359(4):355-65.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright